BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 28368091)

  • 1. De-escalation techniques for psychosis-induced aggression or agitation.
    Du M; Wang X; Yin S; Shu W; Hao R; Zhao S; Rao H; Yeung WL; Jayaram MB; Xia J
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD009922. PubMed ID: 28368091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation).
    Ostinelli EG; Hussein M; Ahmed U; Rehman FU; Miramontes K; Adams CE
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD009412. PubMed ID: 29634083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De-escalation techniques for managing non-psychosis induced aggression in adults.
    Spencer S; Johnson P; Smith IC
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012034. PubMed ID: 30019748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aripiprazole (intramuscular) for psychosis-induced aggression or agitation (rapid tranquillisation).
    Ostinelli EG; Jajawi S; Spyridi S; Sayal K; Jayaram MB
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD008074. PubMed ID: 29308601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation).
    Powney MJ; Adams CE; Jones H
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009377. PubMed ID: 23152276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute interventions for aggression and agitation in psychosis: study protocol for a systematic review and network meta-analysis.
    Ostinelli EG; D'Agostino A; Shokraneh F; Salanti G; Furukawa TA
    BMJ Open; 2019 Oct; 9(10):e032726. PubMed ID: 31601607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haloperidol plus promethazine for psychosis induced aggression.
    Huf G; Alexander J; Allen MH
    Cochrane Database Syst Rev; 2005 Jan; (1):CD005146. PubMed ID: 15654706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haloperidol plus promethazine for psychosis-induced aggression.
    Huf G; Alexander J; Allen MH; Raveendran NS
    Cochrane Database Syst Rev; 2009 Jul; (3):CD005146. PubMed ID: 19588366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlorpromazine for psychosis induced aggression or agitation.
    Ahmed U; Jones H; Adams CE
    Cochrane Database Syst Rev; 2010 Apr; (4):CD007445. PubMed ID: 20393959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia.
    Mühlbauer V; Möhler R; Dichter MN; Zuidema SU; Köpke S; Luijendijk HJ
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013304. PubMed ID: 34918337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Containment strategies for people with serious mental illness.
    Muralidharan S; Fenton M
    Cochrane Database Syst Rev; 2006 Jul; (3):CD002084. PubMed ID: 16855984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personally tailored activities for improving psychosocial outcomes for people with dementia in long-term care.
    Möhler R; Renom A; Renom H; Meyer G
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD009812. PubMed ID: 29438597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.
    Ballard C; Waite J
    Cochrane Database Syst Rev; 2006 Jan; (1):CD003476. PubMed ID: 16437455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early intervention for psychosis.
    Marshall M; Rathbone J
    Cochrane Database Syst Rev; 2006 Oct; (4):CD004718. PubMed ID: 17054213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specialised early intervention teams (extended time) for recent-onset psychosis.
    Puntis S; Minichino A; De Crescenzo F; Cipriani A; Lennox B; Harrison R
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013287. PubMed ID: 33135812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clotiapine for acute psychotic illnesses.
    Carpenter S; Berk M
    Cochrane Database Syst Rev; 2001; (1):CD002304. PubMed ID: 11279762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managed alcohol as a harm reduction intervention for alcohol addiction in populations at high risk for substance abuse.
    Muckle W; Muckle J; Welch V; Tugwell P
    Cochrane Database Syst Rev; 2012 Dec; 12():CD006747. PubMed ID: 23235633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventive interventions for postnatal psychosis.
    Essali A; Alabed S; Guul A; Essali N
    Cochrane Database Syst Rev; 2013 Jun; (6):CD009991. PubMed ID: 23740790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.